Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma-Reference-Cited by-同舟云学术

Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma

Published:2021-12 Issue:12 Volume:141 Page:2908-2920.e7
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Cortes Jose R.^ORCID,Patrone Christina C.^ORCID,Quinn Stuart Aidan^ORCID,Gu Yuhan^ORCID,Sanchez-Martin Marta^ORCID,Mackey Adam^ORCID,Cooke Anisha J.^ORCID,Shih Bobby B.^ORCID,Laurent Anouchka P.^ORCID,Trager Megan H.^ORCID,Ferrando Adolfo A.^ORCID,Geskin Larisa J.^ORCID,Palomero Teresa^ORCID

Funder

National Cancer Institute

Columbia University Irving Medical Center

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference49 articles.

1. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein;Aron;Blood,2003

2. Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data;Bates;Br J Haematol,2015

3. Romidepsin therapy over 5 years in a clinical setting-real-world experience;Bates;JAMA Oncol,2016

4. Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma;Bates;Br J Haematol,2010

5. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation;Boyle;Cell Signal,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma;Journal of Investigative Dermatology;2024-07

2. Cantharidin overcomes IL-2Rα signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species;Journal for ImmunoTherapy of Cancer;2024-07

3. RuBi-Ruxolitinib: A Photoreleasable Antitumor JAK Inhibitor;Journal of the American Chemical Society;2024-05-03

4. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome;Blood;2024-04-11

5. “Next top” mouse models advancing CTCL research;Frontiers in Cell and Developmental Biology;2024-04-10